PURPOSE: Both short- and long-term outcomes for individuals with head and neck cancer (HNCa) may be influenced by multiple factors. Identification of distress in those with HNCa may provide a critical dimension that influences quality of life (QoL). Consequently, this investigation assessed distress and QoL in those with HNCa. METHODS: This study utilized a cross-sectional, self-report survey design. Participants included 49 adults diagnosed with HNCa. Upon assessment, post-diagnosis time ranged between 3-12 months. All participants completed a validated distress screening measure, the Brief Symptom Inventory 18 (BSI-18), and the EORTC general QoL assessment tool (EORTC-QLQ-C30) and HNCa module (EORTC-QLQ-H&N35). RESULTS: Approximately 22% of participants demonstrated clinically significant distress. Additionally, distress was significantly related to QoL status and specific symptoms. CONCLUSIONS: Screening for distress in those with HNCa may permit early identification of problems that influence QoL outcomes. The ability to identify distress early may also facilitate timely intervention to reduce distress and optimize QoL.
PURPOSE: Both short- and long-term outcomes for individuals with head and neck cancer (HNCa) may be influenced by multiple factors. Identification of distress in those with HNCa may provide a critical dimension that influences quality of life (QoL). Consequently, this investigation assessed distress and QoL in those with HNCa. METHODS: This study utilized a cross-sectional, self-report survey design. Participants included 49 adults diagnosed with HNCa. Upon assessment, post-diagnosis time ranged between 3-12 months. All participants completed a validated distress screening measure, the Brief Symptom Inventory 18 (BSI-18), and the EORTC general QoL assessment tool (EORTC-QLQ-C30) and HNCa module (EORTC-QLQ-H&N35). RESULTS: Approximately 22% of participants demonstrated clinically significant distress. Additionally, distress was significantly related to QoL status and specific symptoms. CONCLUSIONS: Screening for distress in those with HNCa may permit early identification of problems that influence QoL outcomes. The ability to identify distress early may also facilitate timely intervention to reduce distress and optimize QoL.
Authors: Nina S Kadan-Lottick; Lauren C Vanderwerker; Susan D Block; Baohui Zhang; Holly G Prigerson Journal: Cancer Date: 2005-12-15 Impact factor: 6.860
Authors: K Bjordal; A de Graeff; P M Fayers; E Hammerlid; C van Pottelsberghe; D Curran; M Ahlner-Elmqvist; E J Maher; J W Meyza; A Brédart; A L Söderholm; J J Arraras; J S Feine; H Abendstein; R P Morton; T Pignon; P Huguenin; A Bottomly; S Kaasa Journal: Eur J Cancer Date: 2000-09 Impact factor: 9.162
Authors: Tanya L Eadie; Devon Otero; Steven Cox; Jordan Johnson; Carolyn R Baylor; Kathryn M Yorkston; Philip C Doyle Journal: Head Neck Date: 2015-12-29 Impact factor: 3.147
Authors: Ellen Passchier; Martijn M Stuiver; Lisette van der Molen; Stefanie I C Kerkhof; Michiel W M van den Brekel; Frans J M Hilgers Journal: Eur Arch Otorhinolaryngol Date: 2015-05-30 Impact factor: 2.503
Authors: Lauren J Breen; Moira O'Connor; Samuel Calder; Vivian Tai; Jade Cartwright; Janet M Beilby Journal: Support Care Cancer Date: 2017-03-03 Impact factor: 3.603
Authors: Nedeljko Jovanovic; Colleen Dreyer; Sarah Hawkins; Kendra Thouless; David Palma; Philip C Doyle; Julie A Theurer Journal: Support Care Cancer Date: 2020-08-01 Impact factor: 3.603
Authors: Melissa Adair; Barbara Murphy; Sujatha Yarlagadda; Jie Deng; Mary S Dietrich; Sheila H Ridner Journal: Integr Cancer Ther Date: 2018-01-22 Impact factor: 3.279